Get the app!
Back to Trades
Grant4

QUEST DIAGNOSTICS INC

DGX

Total Value
$2.1M

Company Information

Ticker Symbol
DGX
CIK
0001022079

Insider Information

Role
SVP, Clinical Solutions
Officer
Location
SECAUCUS, NJ

Filing Details

Filing Date
Feb 20, 2026
Transaction Date
Feb 18, 2026
Accession Number
0001955217-26-000002
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Feb 18, 2026Common Stock252$210.01Tax Withholding$52.9K
Feb 18, 2026Common Stock259$206.99Tax Withholding$53.6K
Feb 18, 2026Common Stock2,135Grant/Award
Jan 28, 2026Common Stock16$183.52Small Acquisition$2.9K

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
Feb 18, 2026Derivative9,853$204.96Grant/Award$2.0M

Footnotes

  1. (F1)Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.
  2. (F2)Represents an award of restricted stock units.
  3. (F3)Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
  4. (F4)The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4.
  5. (F5)These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
  6. (F6)The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.